# Mettler-Toledo (MTD) — Earnings

MTD · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/mtd/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | $11.46 |
| EPS estimate | $10.80 |
| EPS surprise | +6.14% |
| Revenue surprise | −0.13% |
| Revenue | $1.0B |
| Revenue estimate | $1.0B |
| Reported | Jul 30, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1037646/000103764626000051/mtd-20260630.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/1bdd1b9a-cb01-c133-a085-9f1fb227724d.html) |

Mettler-Toledo reported Q2 2026 results on July 30, 2026. Earnings per share were $11.46, ahead of the $10.80 estimate by 6.14%. Revenue was about $1.0 billion, 0.13% below the consensus. Compared with Q2 2025, EPS rose about 14% from $10.09 on revenue up from $983.2 million.

The record shows a clear seasonal pattern. By EPS, Q1 is the weakest quarter each year, and Q4 the strongest in every year but 2023. Q4 2025 holds the EPS high in the table at $13.36, while Q1 2022 is the low at $7.87. Annual EPS was $39.54 in 2022, dipped to $38.08 in 2023, then rose to $41.16 in 2024 and $42.79 in 2025. Quarterly revenue stayed between roughly $0.9 billion and $1.1 billion. The first half of 2026 adds up to $20.37 per share, about 11% more than a year earlier. Mettler-Toledo beat the EPS estimate in 19 of the last 20 quarters. The only miss was Q4 2023, at 6.96% below.

The company reported Q3 between November 3 and November 9 in each of the last five years. That points to early November 2026 for the next report. It will show whether the year-over-year gains continue.

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Jul 30, 2026 | $10.80 | $11.46 | 6.14% | $1.0B | $1.0B |
| Q1 2026 | May 7, 2026 | $8.71 | $8.91 | 2.27% | $943.1M | $947.1M |
| Q4 2025 | Feb 5, 2026 | $12.80 | $13.36 | 4.36% | $1.1B | $1.1B |
| Q3 2025 | Nov 6, 2025 | $10.66 | $11.15 | 4.62% | $997.3M | $1.0B |
| Q2 2025 | Aug 1, 2025 | $9.60 | $10.09 | 5.13% | $957.6M | $983.2M |
| Q1 2025 | May 1, 2025 | $7.88 | $8.19 | 3.91% | $876.6M | $883.7M |
| Q4 2024 | Feb 6, 2025 | $11.72 | $12.41 | 5.86% | $1.0B | $1.0B |
| Q3 2024 | Nov 7, 2024 | $10.01 | $10.21 | 1.97% | $944.8M | $954.5M |
| Q2 2024 | Aug 1, 2024 | $9.03 | $9.65 | 6.84% | $929.1M | $946.8M |
| Q1 2024 | May 9, 2024 | $7.64 | $8.89 | 16.29% | $879.7M | $925.9M |
| Q4 2023 | Feb 8, 2024 | $10.10 | $9.40 | -6.96% | $959.4M | $935.0M |
| Q3 2023 | Nov 9, 2023 | $9.72 | $9.80 | 0.83% | $946.9M | $942.5M |
| Q2 2023 | Jul 27, 2023 | $9.98 | $10.19 | 2.05% | $1.0B | $982.1M |
| Q1 2023 | May 4, 2023 | $8.61 | $8.69 | 0.95% | $921.2M | $928.7M |
| Q4 2022 | Feb 9, 2023 | $11.68 | $12.10 | 3.62% | $1.0B | $1.1B |
| Q3 2022 | Nov 3, 2022 | $9.84 | $10.18 | 3.50% | $972.1M | $985.8M |
| Q2 2022 | Jul 28, 2022 | $8.77 | $9.39 | 7.10% | $951.5M | $978.4M |
| Q1 2022 | May 5, 2022 | $7.28 | $7.87 | 8.04% | $868.5M | $897.8M |
| Q4 2021 | Feb 10, 2022 | $10.10 | $10.53 | 4.27% | $1.0B | $1.0B |
| Q3 2021 | Nov 4, 2021 | $8.28 | $8.72 | 5.32% | $929.5M | $952.0M |

## Frequently Asked Questions

### When did Mettler-Toledo (MTD) last report earnings?

Mettler-Toledo last reported on Jul 30, 2026, covering fiscal Q2 2026.

### Did MTD beat earnings estimates?

Yes. Mettler-Toledo reported EPS of $11.46 for Q2 2026 against a $10.80 estimate — a 6.14% beat.

### How much revenue did MTD report last quarter?

Mettler-Toledo reported $1.0B in revenue for Q2 2026, against a consensus estimate of $1.0B.

## Similar Stocks

- [A](https://www.lighthorse.io/tickers/a) — Agilent Technologies, Inc. Common Stock
- [TMO](https://www.lighthorse.io/tickers/tmo) — Thermo Fisher Scientific Inc Common Stock
- [WAT](https://www.lighthorse.io/tickers/wat) — Waters Corporation Common Stock
- [DHR](https://www.lighthorse.io/tickers/dhr) — Danaher Corporation Common Stock
- [RVTY](https://www.lighthorse.io/tickers/rvty) — Revvity, Inc. Common Stock
- [TECH](https://www.lighthorse.io/tickers/tech) — Bio-Techne Corp - Common Stock
- [IQV](https://www.lighthorse.io/tickers/iqv) — IQVIA Holdings, Inc. Common Stock
- [BRKR](https://www.lighthorse.io/tickers/brkr) — Bruker Corporation - Common Stock
- [RGEN](https://www.lighthorse.io/tickers/rgen) — Repligen Corporation - Common Stock
- [BIO](https://www.lighthorse.io/tickers/bio) — Bio-Rad Laboratories, Inc. Class A Common Stock

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).